Integrative Training in Addictions

What’s new with the NIDA training grant at University of Chicago?

UChicago researchers identify neural circuit implicated in fear suppression

In a new study, Assistant Professor Mark Sheffield and team describe processes involved in suppressing fear tied to a specific situation or environment.

Harriet de Wit, PhD talks to the BBC about how a dose of MDMA transformed a white supremacist

Brendan was once a leader in the US white nationalist movement. But when he took the drug MDMA in a scientific study, it would radically change his extremist beliefs – to the surprise of everyone involved. Rachel Nuwer investigates what happened.

Could drugs like ecstasy or LSD help treat depression or PTSD?

Prof. de Wit’s lab is testing the effects on volunteers. 

Bob Messing, MD joins the NIDA T32 External Advisory Committee

Dr. Messing is the Director of Waggoner Center for Alcohol and Addiction Research Professor, Department of Neurology Chair, Neuroscience Department University of Texas at Austin. 

Xiaoxi Zhuang, PhD named a 2022 fellow of the American Association for the Advancement of Science

Xiaoxi Zhuang was among the 506 fellows elected as AAAS members for their scientifically or socially distinguished efforts to advance science and its applications. Congratulations, Xiaoxi!

The NIDA T32 Training Program at The University of Chicago provides a unique multidisciplinary opportunity for both pre and postdoctoral trainees interested in addiction and substance abuse research.  Our training faculty include world-renowned experts in addiction research at every level, from molecular genetics and cellular approaches, to behavior, epidemiology and treatment.  With this breadth of faculty expertise, we aim to educate trainees in the multiple dimensions of this complex social and biological problem.

The University of Chicago has a long record of commitment to drug abuse research, beginning in 1972 when the NIDA-funded Drug Abuse Research Center was established.  Since then, our faculty have included pioneers of addiction research, including Jerry Jaffe, Lewis Seiden, Daniel X Freedman, Bob Schuster, Marian Fischman and Chris-Ellyn Johanson.   Building on this long tradition, current faculty include leaders in neuropharmacology and behavioral pharmacology of addiction, using both animal models and human subjects, as well as key epidemiological and public policy research. The University has recently expanded its commitment to neuroscience through new investments in genetics as well as systems/computational neuroscience and clinical research. These significant investments create a rich intellectual environment with exciting new opportunities addiction research.